查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
失眠治療全球市場規模研究與預測，按產品（藥物、設備），按銷售渠道（處方藥、非處方藥 (OTC)），按地區，2022-2029 年
市場調查報告書
商品編碼
1251590

失眠治療全球市場規模研究與預測，按產品（藥物、設備），按銷售渠道（處方藥、非處方藥 (OTC)），按地區，2022-2029 年

Global Insomnia Therapeutics Market Size study & Forecast, by Product (Drugs, Device) by Sales Channel (Prescription, Over-the-Counter (OTC))and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球失眠治療市場價值約為 28 億美元，預計在 2022-2029 年預測期內將以超過 5.3% 的強勁增長率增長。

失眠藥物是預防失眠的有效療法。 失眠是一種睡眠障礙，導致入睡困難和難以入睡。 這是一種非常常見的疾病，影響著很多人。 這種疾病有多種原因，包括壓力、睡眠不足、不良睡眠習慣和焦慮。 它還會影響心理健康、工作績效和個人生活質量。 此外，個人壓力的增加以及 COVID-19 對失眠市場的積極影響正在推動失眠藥物市場。

由於多種原因，全球人口壓力水平不斷增加導致失眠，進一步推動了失眠藥物市場。 例如，在 2022 年，50% 的受訪者表示他們的壓力會比前一年更大。 而在 2019 年，這一比例僅為 38%。 壓力來源包括工作量、家庭問題、個人醫療保健和個人心理健康問題。 由於不同的原因，所有年齡組都受到這種睡眠障礙的影響。 大流行 COVID-19 對失眠市場產生了積極影響。 由於失業和不可預見的情況，人們承受著壓力。 此類致命的生活事件導致市場上對失眠藥物的需求激增。 約 67% 的受訪者表示，他們在 2020 年全球大流行期間經歷了更高水平的壓力。 此外，不斷增加的個人繁忙日程以及更好的失眠藥物和配方的不斷進步推動了需求。 然而，失眠藥物的高成本將阻礙整個 2022-2029 年預測期內的市場增長。

全球失眠藥物市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和拉丁美洲其他地區。 北美在失眠藥物市場佔有壓倒性的份額，佔有 54% 的份額。 老年人口的增加和失眠症的高患病率正在推動失眠藥物市場。 主要市場參與者增加研發投資和頻繁推出產品的創新在市場需求中發揮著重要作用。 亞太地區預計將成為增長最快的地區，因為壓力和工作超負荷會影響睡眠並導致失眠。 對睡眠障礙治療的認識不斷提高正在推動市場需求。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年全球和細分市場估計和預測
    • 2019-2029 年按地區分列的失眠藥物市場
    • 失眠治療市場，副產品，2019-2029
    • 失眠治療市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球失眠治療市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章全球失眠藥物市場動態

  • 失眠治療市場影響分析 (2019-2029)
    • 市場驅動因素
      • 壓力增加
      • COVID-19 的積極影響
    • 市場挑戰
      • 失眠藥物的高成本
    • 市場機會
      • 制定的進展
      • 增加繁忙的工作日程

第 4 章全球失眠藥物市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球失眠治療市場：按產品分類

  • 市場概況
  • 全球失眠藥物市場：按產品、按性能 - 潛力分析
  • 全球失眠藥物市場：2019-2029 年按產品估算和預測
  • 失眠治療市場細分分析
    • 藥物
    • 設備

第 7 章全球失眠藥物市場：按分銷渠道

  • 市場概況
  • 全球失眠藥物市場：銷售渠道的性能潛力分析
  • 全球失眠藥物市場：估計和預測（按銷售渠道）2019-2029
  • 失眠治療市場細分分析
    • 處方
    • 場外交易 (OTC)

第 8 章全球失眠藥物市場：區域分析

  • 失眠藥物市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按產品估算和預測
      • 按銷售渠道估算和預測，2019 年至 2029 年
    • 加拿大
  • 歐洲失眠藥物市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區失眠治療市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲的失眠藥物市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 武田製藥有限公司；
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概述
      • 近期趨勢
    • Idorsia Pharmaceuticals Ltd
    • Eisai Co., Ltd.
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi S.A.
    • Electromedical Products International, Inc.
    • Paratek Pharmaceuticals, Inc.
    • Sumitomo Pharma Co., Ltd.

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Insomnia Therapeutics Market is valued at approximately USD 2.8 billion in 2021and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2022-2029.Insomnia Therapeutics is the treatment effective in preventing Insomnia. It is a sleep disorder that creates difficulty for the individual to fall or stay asleep. It is a very common disease prevailing these days and affecting a number of populations. There are several reasons for this disorder such as stress, poor sleep schedules, bad sleeping habits, anxiety and so on. It also affects mental health, work performance and quality of individual life. Additionally, increasing incidences of stress among individuals and the positive impact of COVID-19 on the insomnia market are driving the market for Insomnia Therapeutics.

The increasing stress levels among the global population due to several reasons lead to insomnia further driving the market for Insomnia Therapeutics. For instance, in 2022 50% of respondents were feeling more stressed than in the previousyear. In 2019 the percentage was just 38%. The stress can be due to workload, family issues, personal health care, and individual mental health. All age groups were affected due to this sleep disorder due to different reasons. The pandemic COVID-19 laid a positive impact on the Insomnia market. People suffered from stress due to job losses and unexpected situations. Such a deadly life event surged the demand for insomnia therapeutics in the market. Around 67% of respondents experienced higher levelsof stress during the pandemic globally in 2020. Moreover, the constant rise in hectic schedules of individuals, and continuous advancements and formulations in better insomnia treatment methods boosted the demand. However, the high cost of Insomnia Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Insomnia Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for Insomnia therapeutics with a share of 54%. The growing geriatricc population and high prevalence of insomnia in this population is driving the market for Insomnia Therapeutics. The growing investments of key market players in R&D and innovations through frequent product launches play a major role in market demand. Asia-Pacific is expected to be the fastest-growing region due to increased stress and work schedules affecting sleep among the population is leading to insomnia disorders. The rising awareness to cure for sleep disorders is boosting the market demand.

Major market players included in this report are:

  • Takeda Pharmaceutical Company Ltd.;
  • Idorsia Pharmaceuticals Ltd
  • Eisai Co., Ltd.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Electromedical Products International, Inc.
  • Paratek Pharmaceuticals, Inc.
  • Sumitomo Pharma Co., Ltd.

Recent Developments in the Market:

  • In May 2022, QUVIVIQ a medication to treat adult patients with insomnia launched by Idorsia Ltd received approval from European Commission. The symptoms should be for at least 3 months and impact daytime working.
  • In June 2021, DAYVIGO was launched by Eisai Co., Ltd., a global leader in life science products. This launch was to treat insomnia in adults. It was also approved by U.S. Food and Drug Administration (FDA).

Global Insomnia Therapeutics Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, Sales Channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByProduct:

  • Drugs
  • Device

By Sales Channel:

  • Prescription
  • Over-the-Counter (OTC)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Insomnia Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Insomnia Therapeutics Market, by Product,2019-2029 (USD Billion)
    • 1.2.3. Insomnia Therapeutics Market, by Sales Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Insomnia Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Insomnia Therapeutics Market Dynamics

  • 3.1. Insomnia Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of Stress.
      • 3.1.1.2. Positive Impact of COVID-19.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Insomnia Therapeutics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation.
      • 3.1.3.2. Rising hectic work schedule.

Chapter 4. Global Insomnia Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Insomnia Therapeutics Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Insomnia Therapeutics Market by Product, Performance - Potential Analysis
  • 6.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
  • 6.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. Device

Chapter 7. Global Insomnia Therapeutics Market, by Sales Channel

  • 7.1. Market Snapshot
  • 7.2. Global Insomnia Therapeutics Market by Sales Channel, Performance - Potential Analysis
  • 7.3. Global Insomnia Therapeutics Market Estimates & Forecasts by Sales Channel 2019-2029 (USD Billion)
  • 7.4. Insomnia Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Prescription
    • 7.4.2. Over-the-Counter (OTC)

Chapter 8. Global Insomnia Therapeutics Market, Regional Analysis

  • 8.1. Insomnia Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Insomnia Therapeutics Market
    • 8.2.1. U.S.Insomnia Therapeutics Market
      • 8.2.1.1. Productbreakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Sales Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. CanadaInsomnia Therapeutics Market
  • 8.3. Europe Insomnia Therapeutics Market Snapshot
    • 8.3.1. U.K. Insomnia Therapeutics Market
    • 8.3.2. Germany Insomnia Therapeutics Market
    • 8.3.3. France Insomnia Therapeutics Market
    • 8.3.4. Spain Insomnia Therapeutics Market
    • 8.3.5. Italy Insomnia Therapeutics Market
    • 8.3.6. Rest of EuropeInsomnia Therapeutics Market
  • 8.4. Asia-PacificInsomnia Therapeutics Market Snapshot
    • 8.4.1. China Insomnia Therapeutics Market
    • 8.4.2. India Insomnia Therapeutics Market
    • 8.4.3. JapanInsomnia Therapeutics Market
    • 8.4.4. Australia Insomnia Therapeutics Market
    • 8.4.5. South Korea Insomnia Therapeutics Market
    • 8.4.6. Rest of Asia PacificInsomnia Therapeutics Market
  • 8.5. Latin America Insomnia Therapeutics Market Snapshot
    • 8.5.1. Brazil Insomnia Therapeutics Market
    • 8.5.2. MexicoInsomnia Therapeutics Market
  • 8.6. Rest of The World Insomnia Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Takeda Pharmaceutical Company Ltd.;
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. ProductSummary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Idorsia Pharmaceuticals Ltd
    • 9.2.3. Eisai Co., Ltd.
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Merck & Co., Inc.
    • 9.2.6. Teva Pharmaceutical Industries Ltd.
    • 9.2.7. Sanofi S.A.
    • 9.2.8. Electromedical Products International, Inc.
    • 9.2.9. Paratek Pharmaceuticals, Inc.
    • 9.2.10. Sumitomo Pharma Co., Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Insomnia Therapeutics Market, report scope
  • TABLE 2. Global Insomnia Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Insomnia Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
  • TABLE 4. Global Insomnia Therapeutics Market estimates & forecasts by Sales Channel 2019-2029 (USD Billion)
  • TABLE 5. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Insomnia Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Insomnia Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. SpainInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPACInsomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPACInsomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Insomnia Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Insomnia Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Insomnia Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Insomnia Therapeutics Market, research methodology
  • FIG 2. Global Insomnia Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Insomnia Therapeutics Market, key trends 2021
  • FIG 5. Global Insomnia Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Insomnia Therapeutics Market, porters 5 force model
  • FIG 7. Global Insomnia Therapeutics Market, pest analysis
  • FIG 8. Global Insomnia Therapeutics Market, value chain analysis
  • FIG 9. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Insomnia Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Insomnia Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 16. Europe Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 18. Latin America Insomnia Therapeutics Market2019 & 2029 (USD Billion)
  • FIG 19. Global Insomnia Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable